Parkinson's patients try VR video games to improve balance
NCT ID NCT07038590
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a virtual reality exercise program (exergames) could improve balance and reduce fall risk in people with mild to moderate Parkinson's disease. One hundred participants were randomly assigned to either VR exercise or standard therapy for 3 months. Researchers measured balance, gait, and fall risk before and after the program.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- immersive virtual reality exergame program
- What this could lead to
- If it works, this could offer a more engaging and effective way to improve balance and reduce fall risk in people with Parkinson's.
- What could go wrong
- This is a small, completed trial with 100 participants, so results may not apply to everyone. VR may cause tiredness or discomfort, and the benefit over standard therapy is uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
100 people
The number who actually took part.
- Started
-
Sep 2024
- Finished
-
Dec 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
30 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Suffering from idiopathic PD confirmed by a neurologist. 2. Presenting a stage between 1 and 3 on the Hoehn and Yahr scale. 3. Being able to move around unaided. 4. Absence of dementia with a score on the Mini-Mental State Examination (MMSE) of 18 or higher. 5. Being between 30 and 70 years of age. Exclusion Criteria: 1. Comorbidity that makes physical exercise inadvisable and that prevents all scheduled assessments from being performed. 2. Severe visual and/or hearing disturbances that impede the session. 3. Having a history of vertigo, seizures, or epileptic seizures. 4. Presence of motor fluctuations and/or dyskinesias, gait blockages, or a history of recent falls. 5. Be receiving stable dopaminergic treatment without changes in the previous 3 months and with a prior plan not to change it during the duration of the study. 6. Be receiving second-line therapy (deep brain stimulation or intraduodenal pump). 7. Be participating in another clinical trial. 8. Not attend at least 80% of the immersive virtual reality sessions.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Parkinson disease (PD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Vigo
Pontevedra, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can focused electrical fields deep in the brain ease Parkinson's tremors?
- Vibrating wristband put to the test for Parkinson's relief
- Can a breathing and Nerve-Zapping combo help clear the Parkinson's brain?
- Can group brain training slow Parkinson's cognitive decline?
- Old drug showdown: can benzhexol match procyclidine for Parkinson's tremor?
- Which DBS setting works best for Parkinson's? a trial puts anodic vs cathodic to the test